Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Cattani

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Tumori|July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
The British Journal of Radiology|December 17, 2021
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electronsMaria Cristina Leonardi, Andriana Kouloura, Damaris Patricia Rojas, et al.
Practical Radiation Oncology|July 28, 2024
Hypofractionated Partial Breast Reirradiation in the Conservative Retreatment of Breast Cancer Local RecurrenceMaria Cristina Leonardi, Simona Arculeo, Samuele Frassoni, et al.
Frontiers in Oncology|October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
The British Journal of Radiology|November 1, 2018
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)Barbara Alicja Jereczek-Fossa, Damaris Patricia Rojas, Dario Zerini, et al.
World Journal of Urology|March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
The British Journal of Radiology|May 12, 2018
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218Giorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Journal of Clinical Medicine|March 17, 2025
Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical TomotherapySamantha Dicuonzo, Maria Alessia Zerella, Mattia Zaffaroni, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2019
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breastMaria Cristina Leonardi, Ruggero Spoto, Eleonora Miglietta, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Tumori|July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
The British Journal of Radiology|December 17, 2021
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electronsMaria Cristina Leonardi, Andriana Kouloura, Damaris Patricia Rojas, et al.
Practical Radiation Oncology|July 28, 2024
Hypofractionated Partial Breast Reirradiation in the Conservative Retreatment of Breast Cancer Local RecurrenceMaria Cristina Leonardi, Simona Arculeo, Samuele Frassoni, et al.
Frontiers in Oncology|October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
The British Journal of Radiology|November 1, 2018
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)Barbara Alicja Jereczek-Fossa, Damaris Patricia Rojas, Dario Zerini, et al.
World Journal of Urology|March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
The British Journal of Radiology|May 12, 2018
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218Giorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Journal of Clinical Medicine|March 17, 2025
Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical TomotherapySamantha Dicuonzo, Maria Alessia Zerella, Mattia Zaffaroni, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2019
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breastMaria Cristina Leonardi, Ruggero Spoto, Eleonora Miglietta, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Pageof 13